Prostate cancer is one of the highest diagnosed cancers in the U.S. Less is understood about an advanced stage of the disease known as nmCRPC, where treatment selection is critical. Innovation in this disease state continues, including a new treatment for nmCRPC recently approved by the FDA.
Men with nmCRPC typically do not demonstrate symptoms, are taking other medications for other conditions and don’t often feel the urgency to treat their prostate cancer that has not spread to other parts of the body. But for about one-third of these men, the cancer will metastasize, or spread, within two years.
NUBEQA is a prescription medicine used to treat men with prostate cancer that has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone. Talk with your doctor about whether it's right for you.